Cargando…

COVID-19 vaccination in immunocompromised patients

Detalles Bibliográficos
Autores principales:	Sonani, Bhavin, Aslam, Fawad, Goyal, Amandeep, Patel, Janki, Bansal, Pankaj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797352/ https://www.ncbi.nlm.nih.gov/pubmed/33426632 http://dx.doi.org/10.1007/s10067-020-05547-w

Ejemplares similares

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
por: Bansal, Pankaj, et al.
Publicado: (2020)

Duration of isolation and precautions in immunocompromised patients with COVID-19
por: Taramasso, L., et al.
Publicado: (2021)

Measles-associated pneumonia in an immunocompromised patient: Persistent shortcomings in vaccination guidelines
por: Portais, A., et al.
Publicado: (2021)

“Living with COVID”—implications for immunosuppressed and immunocompromised
por: Nune, A., et al.
Publicado: (2022)

Isolated Aspergillus thyroiditis in an immunocompromised patient
por: Chung, Sungjin, et al.
Publicado: (2010)

Managing Anticoagulation for COVID-19-Related Lung Transplantation
por: Fox, W. Everett, et al.
Publicado: (2023)

COVID-19 vaccination drive in India – Beginning of the end
por: Bansal, Rohit, et al.
Publicado: (2021)

Atypical Chikungunya Virus Infections in Immunocompromised Patients
por: Kee, Adrian C.L., et al.
Publicado: (2010)

Correspondence to: “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.”
por: Bansal, Pankaj, et al.
Publicado: (2021)

Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis
por: Deng, Guangtong, et al.
Publicado: (2023)

Helicobacter pylori and Immunocompromised Children
por: Nutpho, Prakaimuk, et al.
Publicado: (2006)

Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Cerebellious abscesses caused by Nocardia farcinica in an immunocompromised patient
por: Sánchez-Ramos, David, et al.
Publicado: (2022)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

Parsonage–Turner Syndrome Following COVID-19 Vaccine
por: Sharma, Rajaram, et al.
Publicado: (2022)

Cryptococcal mesenteric lymphadenitis in an immunocompromised host
por: Mardi, Kavita, et al.
Publicado: (2012)

Diagnostic performance of interferon-Gamma assay for tuberculosis in immunocompromised patients
por: Su, Shih-Yang, et al.
Publicado: (2013)

A rare case of dysphagia in a severely immunocompromised patient
por: Sioulas, Athanasios D., et al.
Publicado: (2012)

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: van der Linden, Jan W.M., et al.
Publicado: (2016)

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: Alanio, Alexandre, et al.
Publicado: (2016)

First Case of Trueperella bernardiae Bacteremia in an Immunocompromised Patient in Korea
por: Roh, Juhye, et al.
Publicado: (2019)

Persistent Human Metapneumovirus Infection in Immunocompromised Child
por: Abed, Yacine, et al.
Publicado: (2008)

Acute invasive fungal sinusitis in immunocompromised children
por: Kebudi, Rejin
Publicado: (2022)

Cancer Immunotherapy for Immunocompromised Patients: An Often Ignored, yet Vital Puzzle
por: Bajpai, Jyoti
Publicado: (2020)

COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period
por: Bansal, N., et al.
Publicado: (2021)

Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)

Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)

An Enigma of Sudden-Onset Vitiligo after COVID-19 Vaccination: A Literature Review
por: Tiwari, Dinesh, et al.
Publicado: (2023)

Heterogenous antibody and T‐cell responses to SARS‐CoV‐2 mRNA vaccines among immunocompromised young people
por: Lu, Liangjian, et al.
Publicado: (2023)

Pfizer: The miracle vaccine for COVID-19?
por: Badiani, A.A., et al.
Publicado: (2020)

The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19
por: Khan, Fawad A.
Publicado: (2020)

Let's not Clinically Miss Testicular Torsion in Patients Presenting with Lower Abdominal Pain and Vomiting
por: Maheshwari, Pankaj N., et al.
Publicado: (2021)

Profile of Helminthic Infections in Patients Attending a Tertiary Care Hospital with Emphasis on Immunocompromised Patients
por: Kandasamy, Vanathy, et al.
Publicado: (2017)

Tinea Confined to Tattoo Sites - An Example of Ruocco's Immunocompromised District
por: Verma, Shyam B.
Publicado: (2019)

Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid
por: Corbeddu, Marialuisa, et al.
Publicado: (2021)

SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
por: Guetl, Katharina, et al.
Publicado: (2021)

Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
por: Piñana, José Luis, et al.
Publicado: (2022)

COVID‐19‐vaccinated plasma treatment for COVID‐19 patients?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2021)

COVID-19 vaccines for high risk and immunocompromised patients
por: Pavia, Charles S., et al.
Publicado: (2022)

Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
por: Song, Jin-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_korfbmnbhurcopavgfv7vkbqve